Therapeutic Germ Line Alteration: Has CRISPR/Cas9 Technology Forced the Question?
Hum Gene Ther
.
2015 May;26(5):245-6.
doi: 10.1089/hum.2015.28999.tfl.
Epub 2015 Apr 30.
Author
Terence R Flotte
1
Affiliation
1
Incoming Editor-in-Chief.
PMID:
25927157
PMCID:
PMC4442580
DOI:
10.1089/hum.2015.28999.tfl
No abstract available
Publication types
Editorial
MeSH terms
CRISPR-Cas Systems*
Genetic Therapy* / ethics
Genetic Therapy* / legislation & jurisprudence
Genetic Therapy* / methods
Germ Cells / metabolism*
Humans